YINZ/YIDZ

The recent guidelines recommending women wait until 50 to get breast cancer screening doesn't apply to women with BRAC mutations, which are very common among Ashkenazi women, according to Nadja Spiegelman at the Forward's Sisterhood Blog:

Such changes to breast cancer screening protocols are not recommended for women at high risk for the disease. Those women are encouraged to speak with their physicians about when to begin screening.

“For women at high risk, the guidelines are different than those that apply to women who are 40 and have an ordinary risk of breast cancer,” said Rochelle Shoretz, the executive director of Sharsheret — a New Jersey-based organization that provides genetic counseling and support services to young, Jewish women with breast cancer and ovarian cancer.

Here is a story and blog we wrote about the mutation back in October.